Endothelial chimerism in transplantation: Looking for needles in a haystack.
Endothelial chimerism in transplanted organs is a fascinating phenomenon, indicative of a mechanism by which progenitor recipient cells replace the donor endothelium. It has been hypothesized that this replacement could lead to a decrease in alloreactivity and thus would positively influence graft outcome. However, recent studies have shown that the amount of recipient-derived endothelial cells found in donor organs is relatively small. What effect on graft survival can we expect from this low number of chimeric cells? There are several hypotheses that address this question, but distinguishing the true effect of donor endothelial replacement on outcome from other factors affecting graft survival is difficult. Furthermore, "contamination" of chimeric cells from sources other than the recipient would have to be excluded before the effect of donor endothelial replacement by recipient cells can be accurately assessed. Pregnancies and blood transfusions are the other sources that may induce chimerism. Most of the techniques currently used to detect chimeric cells in donor organs are not specific enough to distinguish chimeric cells that may have been present in the graft before transplantation and recipient-derived chimeric cells that replace the endothelium after transplantation. Also, the sensitivity of these techniques may be questioned: do we really detect all chimeric cells that are present? This review will elaborate on these questions and discuss future perspectives of research into chimerism.
Koopmans
Marije
M
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. m.koopmans@lumc.nl
Kremer Hovinga
Idske C L
IC
Baelde
Hans J
HJ
de Heer
Emile
E
Bruijn
Jan A
JA
Bajema
Ingeborg M
IM
D046528:Chimerism; D042783:Endothelial Cells / Q000166:cytology / Q000502:physiology*; D006085:Graft Survival / Q000235:genetics*; D006801:Humans; D016377:Organ Transplantation; D018183:Transplantation Chimera